Abstract
Background: Menorrhagia is a type of menstrual disorder that is characterized by the presence of red vaginal discharge from the uterine cavity on a regular basis, but excessive in quantity (greater than 80 ml) and / or duration (greater than 7 days). Objective: To study the dramatic response of levonorgestrel intrauterine system (LNG-IUS) Mirena for treatment of menorrhagia during its use as contraceptive. Matera and methods: 30 women between 30 and 50 year with menorrhagia were included in a study over two year. Response was assessed monthly for first 4 month and then yearly for maximum 2 year. Result; Mirena caused decrease in blood loss (MBL) in 16.7% of the patients at 4 month, 73.3% decrease in(MBL) by one year and 100% decrease by 2 years, and improved the mean Hb level in 100% of the patients after 2 years. Mirena has an effective in treatment of abnormal uterine bleeding and this made surgical intervention (Hysterectomy) is last choice. Conclusion: LNG locally released on endometrium cavity is both a safe and reliable method of abnormal uterine bleeding treatment.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Advanced Community Medicine
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
